Sheldon Hirsch

558 total citations
14 papers, 415 citations indexed

About

Sheldon Hirsch is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Sheldon Hirsch has authored 14 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Molecular Biology. Recurrent topics in Sheldon Hirsch's work include Metabolism and Genetic Disorders (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Sheldon Hirsch is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Sheldon Hirsch collaborates with scholars based in United States, Austria and Canada. Sheldon Hirsch's co-authors include Stephen L. Gluck, Dennis Brown, Vikas P. Sukhatme, Arnold W. Strauss, Kamran Masood, Brad H. Rovin, Udayan Bhatt, Philip F. Binkley, Robert Townsend and Peter B. Baker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The American Journal of Medicine.

In The Last Decade

Sheldon Hirsch

14 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheldon Hirsch United States 5 332 61 50 50 49 14 415
Jesse W. Bowen United States 9 304 0.9× 47 0.8× 52 1.0× 50 1.0× 33 0.7× 14 445
C. Khadouri France 12 341 1.0× 58 1.0× 113 2.3× 31 0.6× 36 0.7× 14 424
Beth Zavilowitz United States 14 384 1.2× 84 1.4× 142 2.8× 37 0.7× 85 1.7× 20 510
Brian R. Roberts United States 10 262 0.8× 37 0.6× 63 1.3× 44 0.9× 23 0.5× 12 378
Goichi Ogimoto Japan 8 291 0.9× 42 0.7× 54 1.1× 45 0.9× 20 0.4× 12 416
R.J.M. Bindels Netherlands 11 280 0.8× 71 1.2× 92 1.8× 9 0.2× 42 0.9× 20 454
Anie Azroyan France 9 264 0.8× 42 0.7× 71 1.4× 30 0.6× 21 0.4× 10 404
Beate Geist Germany 5 136 0.4× 87 1.4× 62 1.2× 26 0.5× 43 0.9× 7 254
Gustavo Ares United States 10 345 1.0× 54 0.9× 80 1.6× 34 0.7× 35 0.7× 15 454
Pascale Borensztein France 12 313 0.9× 119 2.0× 99 2.0× 18 0.4× 28 0.6× 28 471

Countries citing papers authored by Sheldon Hirsch

Since Specialization
Citations

This map shows the geographic impact of Sheldon Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Hirsch more than expected).

Fields of papers citing papers by Sheldon Hirsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Hirsch. The network helps show where Sheldon Hirsch may publish in the future.

Co-authorship network of co-authors of Sheldon Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon Hirsch. A scholar is included among the top collaborators of Sheldon Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon Hirsch. Sheldon Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hirsch, Sheldon, et al.. (2012). Tolerating Increases in the Serum Creatinine following Aggressive Treatment of Chronic Kidney Disease, Hypertension and Proteinuria: Pre-Renal Success. American Journal of Nephrology. 36(5). 430–437. 23 indexed citations
2.
Hirsch, Sheldon. (2009). Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.. PubMed. 35(2). 91–5. 1 indexed citations
3.
Hirsch, Sheldon. (2007). Prerenal Success in Chronic Kidney Disease. The American Journal of Medicine. 120(9). 754–759. 5 indexed citations
4.
Hirsch, Sheldon. (2006). Preventing end-stage renal disease: flexible strategies to overcome obstacles. Current Opinion in Nephrology & Hypertension. 15(5). 473–480. 8 indexed citations
5.
Vrailas‐Mortimer, Alysia D., et al.. (1996). The expression of the N-methyl-D-aspartate receptor subunit NR-1 messenger RNA in schizophrenia. Schizophrenia Research. 18(2-3). 174–175. 1 indexed citations
6.
Morales, Ana I., et al.. (1990). [Treatment of chronic renal failure: effects of a supplemented diet with essential amino acids].. PubMed. 118(3). 259–63. 1 indexed citations
7.
Starling, Randall C., Peter B. Baker, Sheldon Hirsch, et al.. (1989). An echocardiographic and anatomic description of the donor-recipient atrial anastomosis after orthotopic cardiac transplantation. The American Journal of Cardiology. 64(1). 109–111. 3 indexed citations
8.
Brown, Dennis, Sheldon Hirsch, & Stephen L. Gluck. (1988). Localization of a proton-pumping ATPase in rat kidney.. Journal of Clinical Investigation. 82(6). 2114–2126. 274 indexed citations
9.
Hirsch, Sheldon, et al.. (1988). Isolation and sequence of a cDNA clone encoding the 31-kDa subunit of bovine kidney vacuolar H+-ATPase.. Proceedings of the National Academy of Sciences. 85(9). 3004–3008. 89 indexed citations
10.
Hirsch, Sheldon, et al.. (1980). Lack of blood glucose control in hemodialyzed and renal transplantation diabetics.. PubMed. 26. 362–5. 2 indexed citations
11.
Moya, Francisco, et al.. (1958). HYPERGLYCEMIC ACTION AND TOXICITY OF THE URINE OF SCHIZOPHRENIC PATIENTS. Canadian Journal of Biochemistry and Physiology. 36(5). 505–510. 3 indexed citations
12.
Moya, Francisco, et al.. (1958). HYPERGLYCEMIC ACTION AND TOXICITY OF THE URINE OF SCHIZOPHRENIC PATIENTS. Canadian Journal of Biochemistry and Physiology. 36(1). 505–510. 1 indexed citations
13.
Hirsch, Sheldon. (1952). The Relations between Experimental and Human Arteriosclerosis; a Look at the Campaign against Arteriosclerosis. Cardiology. 20(1). 27–39. 2 indexed citations
14.
Hirsch, Sheldon. (1951). Present aspect of the arteriosclerosis problem; critical review, outlook, needs.. PubMed. 6(1). 73–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026